染色体异常与多发性骨髓瘤的总生存率之间的关联在人口差异
Bei Wang1, Benjamin A Derman2, Madina Sukhanova3
1Department of Public Health Sciences, The University of Chicago, Chicago, IL.
Blood neoplasia
|June 2, 2025
概括
细胞遗传异常对欧洲裔美国人 (EAs) 和非洲裔美国人 (AAs) 的多发性骨髓瘤 (MM) 存活率有不同的影响. 高风险异常会影响EA的存活率,而像del 13q这样的特定异常会影响两组,但t(4;14) 唯一会影响AA的存活率.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 细胞遗传异常是多发性骨髓瘤 (MM) 的关键预后因素.
- 了解不同人群中与这些异常相关的生存差异,特别是欧洲裔美国人 (EAs) 和非洲裔美国人 (AAs),至关重要.
- 现有的研究尚未完全阐明这些人口特异性关联.
研究的目的:
- 研究EA和AA种群中新诊断的MM患者的特定细胞遗传异常和整体存活率 (OS) 之间的关联.
- 确定MM中细胞遗传异常的潜在人口特异性预后意义.
主要方法:
- 在2010-2019年期间,在181名新诊断的MM患者 (55名AA,126名EA) 中,对17个细胞遗传异常的光局部混合化 (FISH) 数据进行了回顾性分析.
- 通过国家死亡指数确定生命状态;来自电子病历的临床数据.
- 细胞遗传异常与OS之间的关联的统计评估,对预后因素和其他高风险细胞遗传异常 (HRCAs) 的控制.
主要成果:
- 细胞遗传异常的分布在EA和AA种群之间类似.
- 高风险MM (由HRCAs定义) 与EA (HR 2.6) 的更糟糕的OS有关,但不是AA.
- 在这两种人群中,del 13q与更糟糕的生存状况有关. 1q的增加/放大在EA中恶化了OS (HR 3.44),而t(4;14) 在AA中显著恶化了OS (HR 14.51).
结论:
- 细胞遗传异常对多发性骨髓瘤患者的整体存活期具有差异性预后意义,基于种族.
- 1q和HRCAs的增加/放大预示着EA的生存率较低,而t(4;14) 是AA的特别糟糕的预后标志物.
- 这些发现强调了在多发性骨髓瘤的预后评估和管理中考虑人口异质性的重要性.
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
303
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
303
01:21Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K